Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Walker

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Molecular Cancer Therapeutics|April 18, 2009
Aminopeptidase inhibition as a targeted treatment strategy in myelomaHannah E Moore, Emma L Davenport, Emma M Smith, et al.
Oncogene|September 10, 2021
Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myelomaChuanpeng Dong, Annamaria Cesarano, Giuseppe Bombaci, et al.
Plos One|March 10, 2012
A modified method for whole exome resequencing from minimal amounts of starting DNAIwanka Kozarewa, Juan Manuel Rosa-Rosa, Christopher P Wardell, et al.
Research Square|August 30, 2023
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Leukemia & Lymphoma|June 11, 2014
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescuePing Wu, Brian A Walker, Annemiek Broyl, et al.
Blood|May 11, 2012
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
European Journal of Haematology|October 27, 2020
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNAShayu Deshpande, Ruslana G Tytarenko, Yan Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 8, 2021
Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple MyelomaJessica Caro, David Cairns, Tom Menzies, et al.
British Journal of Haematology|May 31, 2013
Improved risk stratification in myeloma using a microRNA-based classifierPing Wu, Luca Agnelli, Brian A Walker, et al.
Journal of Hematology & Oncology|August 9, 2020
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myelomaSamrat Roy Choudhury, Cody Ashby, Ruslana Tytarenko, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Molecular Cancer Therapeutics|April 18, 2009
Aminopeptidase inhibition as a targeted treatment strategy in myelomaHannah E Moore, Emma L Davenport, Emma M Smith, et al.
Oncogene|September 10, 2021
Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myelomaChuanpeng Dong, Annamaria Cesarano, Giuseppe Bombaci, et al.
Plos One|March 10, 2012
A modified method for whole exome resequencing from minimal amounts of starting DNAIwanka Kozarewa, Juan Manuel Rosa-Rosa, Christopher P Wardell, et al.
Research Square|August 30, 2023
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Leukemia & Lymphoma|June 11, 2014
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescuePing Wu, Brian A Walker, Annemiek Broyl, et al.
Blood|May 11, 2012
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
European Journal of Haematology|October 27, 2020
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNAShayu Deshpande, Ruslana G Tytarenko, Yan Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 8, 2021
Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple MyelomaJessica Caro, David Cairns, Tom Menzies, et al.
British Journal of Haematology|May 31, 2013
Improved risk stratification in myeloma using a microRNA-based classifierPing Wu, Luca Agnelli, Brian A Walker, et al.
Journal of Hematology & Oncology|August 9, 2020
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myelomaSamrat Roy Choudhury, Cody Ashby, Ruslana Tytarenko, et al.
Pageof 14